Skip to content

High-Purity Type I Collagen Augmentation in Meniscal Repair

Safety and Early Clinical Performance of High-Purity Type I Collagen Augmentation in Arthroscopic Meniscal Repair: A Prospective Feasibility Study

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07352410
Enrollment
18
Registered
2026-01-20
Start date
2026-01-03
Completion date
2026-03-08
Last updated
2026-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Arthroscopy (for Diagnostic or Therapy), Knee Meniscus Injury, Meniscal Repair, Meniscus Tear

Keywords

Meniscal Tear, Meniscus Injuries, Knee Injuries, Arthroscopic Meniscal Repair, Meniscus Preservation, Biologic Augmentation, Collagen Scaffold, Type I Collagen, Cartilage Repair, Tissue Engineering

Brief summary

This prospective, single-arm feasibility study evaluates the safety, procedural feasibility, and early clinical outcomes of High-Purity Type I Collagen used as an adjunct in arthroscopic meniscal repair. The study aims to generate preliminary clinical, functional, and imaging data to inform the design of a future randomized controlled trial.

Detailed description

Meniscal preservation is critical for long-term knee joint health, yet healing failure remains a concern, particularly in avascular zones. High-Purity Type I Collagen serves as a bioactive scaffold promoting cellular migration and early tissue integration. This study assesses early safety signals, feasibility metrics, patient-reported outcomes, and MRI-based healing characteristics following collagen-augmented meniscal repair.

Interventions

DEVICEHigh-Purity Type I Collagen

Standard arthroscopic meniscal repair performed using established techniques (inside-out, outside-in, or all-inside). High-Purity Type I Collagen mesh is trimmed and applied over or within the repair site and secured using sutures or fibrin sealant, according to intra-operative requirements.

Sponsors

Adichunchanagiri Institute of Medical Sciences, B G Nagara
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

* Age 18 to 55 years * Symptomatic meniscal tear confirmed on MRI and indicated for arthroscopic repair * Tear patterns amenable to repair * Stable knee or concomitant ACL reconstruction permitted * Ability to comply with rehabilitation and follow-up * Written informed consent provided

Exclusion criteria

* Advanced knee osteoarthritis (Kellgren-Lawrence grade ≥3) * Irreparable meniscal tears requiring meniscectomy * Active joint infection or inflammatory arthritis * Prior surgical repair of the index meniscus * Known hypersensitivity to collagen products * Systemic conditions impairing wound healing

Design outcomes

Primary

MeasureTime frameDescription
Safety of High-Purity Type I Collagen AugmentationFrom surgery to 2 months post-operativelyIncidence of device-related adverse events, including infection, inflammatory reactions, synovitis, or need for re-operationfollowing collagen-augmented meniscal repair.

Secondary

MeasureTime frameDescription
Pain Reduction Using Visual Analog Scale (VAS)Baseline, 6 weeks, and 8 weeksChange in patient-reported knee pain measured using the Visual Analog Scale. Pain intensity was assessed using a 10-point Visual Analog Scale (VAS) ranging from 0 to 10, where 0 represents no pain and 10 represents the worst imaginable pain. Lower scores indicate less pain and better clinical status, while higher scores indicate greater pain severity and worse symptoms.
Functional Outcome Using IKDC Subjective Knee ScoreBaseline and 2 monthsChange in knee function assessed using the International Knee Documentation Committee (IKDC) subjective knee score, a patient-reported outcome measure assessing symptoms, knee function, and ability to perform daily and sports activities. Scores range from 0 to 100, where 0 represents the worst possible knee function and 100 represents normal knee function without limitations. Higher scores indicate better knee function, and an increase in score represents clinical improvement.
Functional Outcome Using Lysholm Knee ScoreBaseline and 2 monthsKnee stability and functional performance were evaluated using the Lysholm Knee Scoring Scale, a validated questionnaire assessing pain, instability, swelling, limp, locking, and stair climbing ability. The total score ranges from 0 to 100, where higher scores indicate better knee function and fewer symptoms. A score of 100 represents optimal knee function, while lower scores indicate increasing levels of impairment. Therefore, an increase in Lysholm score represents clinical improvement.
Early Meniscal Healing on MRI2 months post-operativelyMRI-based assessment of meniscal integrity, signal intensity at the repair site, and presence of fluid clefts or displacement. Participants with non-interpretable or unavailable MRI were categorized as 'Not assessable'.

Countries

India

Contacts

STUDY_CHAIRPrema Dhanraj, MS, MCh

Rajarajeshwari Medical College and Hospital

Baseline characteristics

Characteristic
Age, Continuous29.6 years
STANDARD_DEVIATION 6.4
Longitudinal/Bucket-handle tears13 Participants
Meniscus Tear Side
Lateral Meniscus Tear
8 Participants
Meniscus Tear Side
Medial Meniscus Tear
10 Participants
Region of Enrollment
India
18 Participants
Sex: Female, Male
Female
7 Participants
Sex: Female, Male
Male
11 Participants
Tear Zone
ed-White Zone Tears
11 Participants
Tear Zone
Red-Red Zone Tears
7 Participants
Time from Injury to Surgery (weeks)3.4 weeks
STANDARD_DEVIATION 1.2

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 18
other
Total, other adverse events
0 / 18
serious
Total, serious adverse events
0 / 18

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 9, 2026